These findings collectively demonstrate that ARV-771 may suppress growth of HCC via reducing the expression of USP1, USP8, USP10, USP13, and USP18 without altering the overall balance of ubiquitination control or leading to proteasome inhibition. Here, USP13 is linked to hepatocellular carcinoma.